FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2017

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
IMMUNO-HEMATOLOGY TRANSFUSION MEDICINE
PAPER-III
IHTM/D/17/15 /III
TIME 3 HOURS
MAX. MARKS 100
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space
• Answer all the parts of a single question together.
• Start the question to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write Short notes on:
1. a. Discuss indications for cryoprecipitate.
b. How would you ensure good yield of FVIII in a unit of cryoprecipitate?
4+6
2. a. Laboratory diagnosis of Neonatal Alloimmune Thrombocytopenia
(NAIT)
b. Discuss transfusion support in NAIT.
5+5
3. a. Audit in transfusion medicine
b. How will you perform audit of red cell transfusion practices in neonatal
care units?
5+5
4. Describe merits and demerits of donor deferral criteria in India with respect
to past history of jaundice.
10
5. a. Differential diagnosis of Transfusion Associated Dyspnoea
b. Outline the plan of investigation in TAD
5+5
6. "Fresh whole blood is a better option than components for transfusion
support in trauma patients". Critically analyse this statement.
10
7. a. Principles of blood inventory management
b. What is "WAPI and ISI" in relation to blood inventory management?
5+5
8. What factors would you consider prior to implementing a screening test for
any new infection on all blood donations in the country?
10
9. a. Laboratory diagnosis of Disseminated Intravascular Coagulation
b. Transfusion support in a case of DIC
5+5
10. Discuss transfusion support in following conditions:
a. Bombay phenotype patient
b. Patient with IgA deficiency
5+5